Financhill
Sell
35

DRIO Quote, Financials, Valuation and Earnings

Last price:
$0.72
Seasonality move :
-5.03%
Day range:
$0.71 - $0.78
52-week range:
$0.50 - $1.93
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.02x
P/B ratio:
0.42x
Volume:
172K
Avg. volume:
247.5K
1-year change:
-58.78%
Market cap:
$30M
Revenue:
$27M
EPS (TTM):
-$0.85

DRIO Analysts' Consensus Rating

The 3 analysts providing 12-month price projections for DarioHealth shares anticipate an average target of $2.33, ranging from a low estimate of $1.00 to a high estimate of $4.00. This average target implies a growth of 223.49% compared to the current stock price of $0.72.

Consensus Price Target

$2.33

Highest Price Target

$4.00

Lowest Price Target

$1.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 0 2

Hold 0 0 1

Sell 0 0 0
Consensus Buy -- Buy

DRIO Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 42x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is down 31.81% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 24.57% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 24.64% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock